Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Zealand Pharma A/S (ZLDPF : OTC)

• Company Description    Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended for use in a dual-hormone artificial pancreas system for better hypoglycemia control and diabetes management and other earlier-stage clinical and preclinical peptide therapeutics are in clinical stage. Zealand Pharma A/S is based in Copenhagen, Denmark. Number of Employees: 335

• Price / Volume Information    Yesterday's Closing Price: $59.56 Daily Weekly Monthly 20 Day Moving Average: 867 shares Shares Outstanding: 71.02 (millions) Market Capitalization: $4,230.19 (millions) Beta: 0.68 52 Week High: $141.74 52 Week Low: $54.95 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -19.65% -22.66% 12 Week -8.11% -22.71% Year To Date -41.81% -45.51%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Sydmarken 11 Soborg - Copenhagen,G7 2860 DNK ph: 45-8877-3600 fax: 45-8877-3898 investors@zealandpharma.com http://www.zealandpharma.com

• General Corporate Information    Officers Adam Steensberg - Chief Executive Officer and President Martin Nicklasson - Chairman of the Board of Directors Ivan Moller - Executive Vice President;Chief Operating Officer Henriette Wennicke - Executive Vice President and Chief Financial Offic Bernadette Connaughton - Director Peer Information Zealand Pharma A/S (CORR.) Zealand Pharma A/S (RSPI) Zealand Pharma A/S (CGXP) Zealand Pharma A/S (BGEN) Zealand Pharma A/S (GTBP) Zealand Pharma A/S (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: K9898X127 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/21/25 Share - Related Items Shares Outstanding: 71.02 Most Recent Split Date: (:1) Beta: 0.68 Market Capitalization: $4,230.19 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.18 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $13.43 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/21/25

• Fundamental Ratios P/E Current FY Estimate: 4.43 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.61 Price/Cash Flow: - Price / Sales: 528.05 EPS Growth vs. Year Ago Period: -24.07% vs. Previous Quarter: -13.56% Sales Growth vs. Year Ago Period: -48.07% vs. Previous Quarter: -11.89% ROE 06/30/25 - - 03/31/25 - -13.40 12/31/24 - -14.46 ROA 06/30/25 - - 03/31/25 - -12.28 12/31/24 - -13.07 Current Ratio 06/30/25 - - 03/31/25 - 25.10 12/31/24 - 21.14 Quick Ratio 06/30/25 - - 03/31/25 - 25.07 12/31/24 - 21.11 Operating Margin 06/30/25 - - 03/31/25 - -2,127.09 12/31/24 - -1,725.03 Net Margin 06/30/25 - - 03/31/25 - -2,127.09 12/31/24 - -1,725.03 Pre-Tax Margin 06/30/25 - - 03/31/25 - -2,136.10 12/31/24 - -1,728.27 Book Value 06/30/25 - - 03/31/25 - 16.51 12/31/24 - 17.59 Inventory Turnover 06/30/25 - - 03/31/25 - 0.64 12/31/24 - 2.07 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.03 12/31/24 - 0.03 Debt-to-Capital 06/30/25 - - 03/31/25 - 3.37 12/31/24 - 3.21

Powered by Zacks Investment Research ©